Akums Drugs and Pharmaceuticals Limited Financial Overview
Akums Drugs and Pharmaceuticals Limited's market cap is currently ₹66.62B. The company's EPS TTM is ₹2.6; its P/E ratio is 20.41; Akums Drugs and Pharmaceuticals Limited is scheduled to report earnings on November 13, 2025, and the estimated EPS forecast is ₹―. See an overview of income statement, balance sheet, and cash flow financials.
